GENTAMICIN CLEARANCE DURING HEMODIALYSIS - A COMPARISON OF HIGH-EFFICIENCY CUPRAMMONIUM RAYON AND CONVENTIONAL CELLULOSE ESTER HEMODIALYZERS

被引:14
作者
AGARWAL, R
TOTO, RD
机构
[1] Division of Nephrology, Department of Internal Medicine, University of Texas, Southwestern Medical Center at Dallas, Dallas, Texas
关键词
GENTAMICIN; HEMODIALYSIS; PHARMACOKINETICS; RENAL FAILURE;
D O I
10.1016/S0272-6386(12)70321-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The advent of high-efficiency hemodialyzers has afforded improved efficiency of urea clearance; however, increased clearance of other substances, particularly antibiotics, also may occur, necessitating changes in clinical practice. Accordingly, we compared the efficiency of gentamicin removal using two different hemodialyzers, a conventional saponified cellulose ester (CD 135) and a high-efficiency cuprammonium rayon dialyzer (TAF 175L), in eight hospitalized patients undergoing antibiotic therapy for suspected or proven gram-negative infection. The rate of dialysis, estimated as the ratio of dialyzer urea clearance (K) to urea distribution volume (V) (K/V urea), and the total elimination rate constant (k) of gentamicin were measured during 17 hemodialysis treatments. The K/V urea for the two dialyzers, TAF 175L and CD 135, was 0.390 ± 0.024 hr-1 and 0.413 ± 0.129 hr-1 (P = NS), respectively. The TAF 175L hemodialyzer was almost twice as efficient in removing gentamicin as the CD 135: TAF 175, k = 0.263 ± 0.024 hr-1; CD 135, k = 0.132 ± 0.027 hr-1 (P < 0.001). Moreover, the rate of dialysis (K/V urea) was correlated with k of gentamicin for the TAF 175L dialyzer (r2 = 0.50, P < 0.02) but not for the CD 135 dialyzer. We conclude that dialyzer characteristics and the rate of dialysis (K/V urea) should be taken into consideration when determining the dosage of gentamicin in patients on hemodialysis. © 1993, National Kidney Foundation, Inc.. All rights reserved.
引用
收藏
页码:296 / 299
页数:4
相关论文
共 15 条
[1]  
BABB AL, 1972, T AM SOC ART INT ORG, V18, P98
[2]   GENTAMICIN PHARMACOKINETICS DURING HEMODIALYSIS [J].
CHRISTOPHER, TG ;
KORN, D ;
BLAIR, AD ;
FOREY, AW ;
ONEILL, MA ;
CUTLER, RE .
KIDNEY INTERNATIONAL, 1974, 6 (01) :38-44
[3]   HEMODIALYZER CLEARANCES OF GENTAMICIN, KANAMYCIN, TOBRAMYCIN, AMIKACIN, ETHAMBUTOL, PROCAINAMIDE, AND FLUCYTOSINE, WITH A TECHNIQUE FOR PLANNING THERAPY [J].
CHRISTOPHER, TG ;
BLAIR, AD ;
FORREY, AW ;
CUTLER, RE .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1976, 4 (05) :427-441
[4]   PHARMACOKINETICS OF GENTAMICIN AND KANAMYCIN DURING HEMODIALYSIS [J].
DANISH, M ;
SCHULTZ, R ;
JUSKO, WJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1974, 6 (06) :841-847
[5]   PREDICTABILITY OF SERUM CONCENTRATIONS OF AMINOGLYCOSIDES AFTER HEMODIALYSIS [J].
DIJKMANS, BAC ;
MATTIE, H .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (02) :179-183
[6]   PREDICTION OF SERUM GENTAMICIN CONCENTRATIONS IN PATIENTS UNDERGOING HEMODIALYSIS [J].
GOETZ, DR ;
PANCORBO, S ;
HOAG, S ;
BLOOM, P .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (08) :1077-1083
[7]   A MECHANISTIC ANALYSIS OF THE NATIONAL COOPERATIVE DIALYSIS STUDY (NCDS) [J].
GOTCH, FA ;
SARGENT, JA .
KIDNEY INTERNATIONAL, 1985, 28 (03) :526-534
[8]   CLEARANCE OF GENTAMICIN DURING HEMODIALYSIS - COMPARISON OF 4 ARTIFICIAL-KIDNEYS [J].
HALPREN, BA ;
AXLINE, SG ;
COPLON, NS ;
BROWN, DM .
JOURNAL OF INFECTIOUS DISEASES, 1976, 133 (06) :627-636
[9]  
HERRERO A, 1988, INT J CLIN PHARM TH, V26, P505
[10]  
Hoenich N, 1989, REPLACEMENT RENAL FU, P144